Mutation...

 

Wonderful. Awesome. Fantastic. Those are the adjectives Emory University researcher Mehul Suthar used to describe the immunity levels seen just after the second dose of Moderna’s COVID-19 vaccine.

But Suthar and colleagues at Emory’s Vaccine Center found that stunning immunity dulled after six months but not to such an extent that the vaccine was ineffective. In fact, Suthar estimated that in three age groups studied – 18-to-55, 56-to-70 and 71-and-older – neutralizing antibodies should linger for one to two years.

“The 484 mutation has been identified by several groups, that it seems to escape antibody responses,” Suthar said. “Other groups are finding that mutations within what’s called the N-terminal domain of that spike protein also encode for escape antibodies.”

Lemon...

 

Hammer...

 

Slanted...

 

When...

The economic pressure on the city’s finances is stark: the Independent Budget Office suggested that the loss in tax revenue may be even worse than the city was predicting.

Because the city’s economy is densely interwoven, reviving it is likely to be a halting process.

Swiftly shutting down the city’s more than 25,000 restaurants and bars was one thing. But getting customers back may not be a matter of simply allowing them to reopen, even with servers in masks and gloves and diners ordering from an app on their phones.

“When are companies going to start hosting events at restaurants and bars again?”  “When are the tourists going to start coming back?”

That is a question that has been haunting Broadway and the rest of the city’s entertainment sector as well.

The Beef...

 

At this time I have more questions than answers about the current Covid-19 Vaccines.

First: The Food and Drug administration authorized the use of these vaccines under Emergency Use Only. In other words, it is not approved just for the use of every one. The benefits should outweigh the risk.  And there is risk here associated with the current practice.

Second: The duration of protection from these vaccines are not identified yet. Pfizer said it protects for more than 6 months.

Third: We don't even have enough information about the elderly who have been vaccinated. How effective the vaccines are, how many vaccinated, who contracted the disease, how many died, what problems are happening from the vaccines, and when would it be the after Six Month start of revaccination for the elderly?

Fourth: I see the marching drums from the politicians on a daily basis standing in front of the Camera and saying ...... I would like one of these Media outlet to end the conference with one reporter asking   "Where Is The Beef"  

We vaccinated millions, the best in the world...  Hurd Immunity, New variants, then Curve and Percent which appears to be a moving target. So far no tangible results to be measured?

Just a thought

Unifier...

 

Signs...

 

These are true signs. 

If you can't see it, better check with your doctor.  Just a thought.

S. Africa...

 

Pfizer's and BioNTech's vaccine has been a phenomenal success story, from the breathtakingly fast development to the jaw-dropping efficacy. And now there's even more good news. Here's why Pfizer's and BioNTech's COVID vaccine could be even better than expected.

A new trial took place in South Africa, where the variant, known as B.1.351, first emerged. Some scientists worry that it might be able to escape existing vaccines.  

In the Pfizer-BioNTech trial, six cases of the variant were observed, none of them in people who had been given the vaccine.

There have been 312 identified cases of the strain in the U.S., according to the latest figures from the CDC.  

Success of the Pfizer Vaccines  against South Africa variant appears to be 100 %.

Keep our fingers crossed. Just a thought.

Ball...